Pulmonary embolism
186 results
1 - 100
Pulmonary embolism common in patients with first episode of syncope (PESIT)- Low prevalence of pulmonary embolism in patients who present to ED with syncope
- Pulmonary embolism rule-out criteria reduces the need for CT pulmonary angiography in low-risk patients (PERC)
- Pulmonary Embolism (PE) Severity Index predicts low risk PE patients.
- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Concurrent COVID-19 infection does not affect the sensitivity of D-dimer for pulmonary embolism diagnosis
- Risk of recurrent venous thromboembolism is 3% in patients with subsegmental pulmonary embolism who are not anticoagulated
- Very few patients with syncope have pulmonary emboli
- YEARS clinical decision tool decreases CT angiography in patients with suspected PE
- Guideline for Dx of PE in pregnant women
- Normal hs troponin and PESI score of 0 means great prognosis for PE
- Multidetector CT accurate for PE, but requires clinical context
- LMWH better than UFH for acute DVT
- Clinical decision rules similarly effective in excluding PE
- Oral rivaroxaban as effective as standard therapy for treatment of acute PE
- Thrombolysis for PE reduces rate of all-cause mortality but increases risk of major bleeding
- LMWH = UFH for thrombocytopenia
- YEARS algorithm helpful for evaluating suspected PE in pregnant women
- Fibrinolysis for intermediate-risk PE: increased bleeding, no mortality effect
- Temporary IVC filter added to anticoagulation does not decrease risk of PE recurrence
- Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
- Idraparinux effective for DVT but not for PE
- Low risk of DVT after knee arthroscopy
- Guidelines for managing VTE (AAFP, ACP)
- Wells score plus age-adjusted d-dimer rules out more PEs
- Low-risk patients with PE can be treated as outpatients
- Increasing the D-dimer threshold for patients with low clinical pretest probability effectively rules out PE (PEGeD)
- Edoxaban noninferior to warfarin for venous thromboembolism anticoagulation
- Third-generation oral contraceptives associated with greater risk of PE, stroke, and MI
- Are inferior vena cava filters overused?
- ACCP 2016: updated guidelines for VTE
- Rosuvastatin prevents DVT at very high cost
- Age-adjusted D-dimer cutoff levels more accurate for PE diagnosis (ADJUST-PE)